Obesity Treatment is Being Explored Through the Development of Oral Medications that Function as GLP- 1 Receptor Agonists Semaglutide A randomized, double-blind, phase III study found that giving adults overweight or obese (without T2DM) 50 mg of oral semaglutide once daily for 68 weeks, in addition to diet and exercise, significantly reduced their body weight in comparison with a placebo (15% vs
The synthetic Tb-500 version replicates the active portion of this naturally occurring protein, enabling researchers to study and apply its regenerative properties
L.Garca-DomnguezJ.AriasJ
When activated, mast cells release a cascade of inflammatory mediators, including: This can disrupt the BBB, promote leukocyte infiltration, and create a pro-inflammatory CNS microenvironment
Avoid REGEN if pregnant, breastfeeding, or trying to conceive due to lack of safety data in these populations
The arginate salt solves this problem with remarkable efficiency